Erika Maria de Oliveira Ribeiro

Dr. Erika Maria de Oliveira Ribeiro


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in REVISTA DELOS
Verified
Journal Article
Open access
PDF file
DBDanilo Luís de Jesus Batista
Danilo Luís de Jesus Batista
YRYgor Jessé Ramos
Ygor Jessé Ramos
NLNeirison Nepomuceno Lima
Neirison Nepomuceno Lima
FGFerdinando Lucas Góis
Ferdinando Lucas Góis
ERErika Maria de Oliveira Ribeiro
Erika Maria de Oliveira Ribeiro
AVAdemir Evangelista Do Vale
Ademir Evangelista Do Vale
The genus Physalis L. (Solanaceae) stands out for its remarkable biological diversity, encompassing more than 75 species used for both food and medicinal purposes. Physalis angulata L., an herbaceous plant widely distributed in tropical and subtropical regions, has been traditionally employed in folk medicine across several countries, including Brazil, Mexico, Peru, Indonesia, and China, where it is known as “Ku-Zhi” and used for treating dermatitis, tracheitis, malaria, rheumatism, and hepatitis. This study conducted a systematic literature review in indexed scientific databases (Scopus, Science Direct, and PubMed), identifying 799 articles, of which 32 were selected for detailed analysis. The reported pharmacological activities include antihyperglycemic, antileishmanial, anti-inflammatory, antifibrotic, antimicrobial, and immunomodulatory effects. Additionally, a patent survey was carried out in indexed databases (Espacenet, INPI, and LATIPAT), resulting in the selection of 28 patents, with the highest concentration in the A61K – Cosmetics category. This review highlights the bioactive metabolites isolated from P. angulata and their therapeutic properties demonstrated in in vitro and in vivo studies, while also assessing its technological potential through patent filings.

19 November 2021 in European Journal of Medicinal Plants
Verified
Journal Article
Closed access
PDF file
FGFerdinando Lucas Góis
Ferdinando Lucas Góis
AVAdemir Evangelista Do Vale
Ademir Evangelista Do Vale
GRGislane Oliveira Ribeiro
Gislane Oliveira Ribeiro
ERErika Maria de Oliveira Ribeiro
Erika Maria de Oliveira Ribeiro
Traditional medicine products are easily found in different regions of the world. Given this scenario, the World Health Organization (WHO) is very interested in the rational insertion of these resources, especially in primary pharmaceutical care in emerging countries. One of the main concerns of the WHO is with the population's access to traditional medicine products without quality guaranteed by regulatory and health control agencies in the country of origin. In ancient Chinese Pharmacology and Medicine, products based on associated drugs, used by boiling in water (decoction), successfully contribute to maintaining the health of Chinese people. In Brazil, the sanitary legislation of herbal mixtures for medicinal teas allows the sanitary notification of these products as traditional herbal medicines. On the other hand, the lack of clinical services to monitor consumption and the scarcity of evidence to ensure safety and efficacy, add to the inadequacy of the products to sanitary standards, the lack of inspection, and the definition of quality parameters for the evaluation of mixtures. Due to the chemical complexity of herbal mixtures, the correct identification of drugs through conventional techniques is usually possible for individual species, making it necessary to develop more comprehensive approaches. These testes allow to investigate the presence and/or absence of multiple pre-established markers, through the concept of fingerprint similarity and evaluation by chemometric tools. Liquid chromatography integrated with mass spectrometry and multivariate data analysis proved to be the most used method. Among the objectives of this critical and prospective review are: to describe the probable origin of medicinal teas, the theoretical foundation of the compositions in pharmacology and traditional Chinese medicine, the modern techniques developed in the quality control of herbal mixtures, and the perspectives for rational and safe insertion of traditional herbal medicines in Brazilian pharmaceutical care.

15 May 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Ivana Patrícia Dos SantosIvana Patrícia Dos Santos
Ivana Patrícia Dos Santos
MCMaria Eduarda V. Costa
Maria Eduarda V. Costa
GOGeovana Alves de Oliveira
Geovana Alves de Oliveira
FSFrancisnaira Da Silva Santos
Francisnaira Da Silva Santos
DVDébora O. S. Vitória
Débora O. S. Vitória
ERErika Maria de Oliveira Ribeiro
Erika Maria de Oliveira Ribeiro
The flavonoids constitute a class of secondary metabolites distributed in plants, occurring in free form (aglycone) or conjugated sugars (glycosides), and are notable for their recognized pharmacological potential. This study investigated flavonoids isolated from the leaves of Erythroxylum rimosum, correlating their chemical structures with biological activities evaluated in vitro assays. The flavonoids did not show significant cytotoxicity in mammalian cells (CC50 > 100 μM), while flavonoids 4 and 5, glycosylated with six-carbon sugar, inhibited the promastigote forms of L. braziliensis with IC50 of 10.34 ± 0.70 μM and 10.14 ± 0.50 μM, respectively. In intracellular infection models, they reduced ~43% of parasitized cells and ~40% of amastigotes. Scanning electron microscopy demonstrated changes in promastigotes, including loss of membrane integrity and flagellum shortening. A molecular docking study with L. mexicana arginase suggested enzyme inhibition as a possible mechanism of action, influenced by sugar chirality. In the antioxidant evaluation, using the DPPH and β-carotene methods, quercetin showed the best inhibitory concentration value (IC50 = 0.22 ± 0.94 mg/mL), followed by glycoside 5 (IC50 = 0.42 ± 0.09 mg/mL). In addition, the flavonoids glycosylated with five-carbon sugar inhibited the acetylcholinesterase enzyme.